drugset

drugset / Trial / NCT00395863

Multihance at 3 Tesla (3T) in Brain Tumors

NCT00395863 ↗

Phase 4 Completed 46 enrolled Bracco Diagnostics, Inc

RandomizedCrossoverTriple-blindDiagnostic

Summary

Compare the efficacy of MultiHance and Magnevist

Timeline

Start: 2006-11
Primary completion: 2008-02
Completion: 2008-03

Publications

Results Rumboldt Z, Rowley HA, Steinberg F, Maldjian JA, Ruscalleda J, Gustafsson L, Bastianello S. Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla. J Magn Reson Imaging. 2009 Apr;29(4):760-7. doi: 10.1002/jmri.21695.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Gadobenate dimeglumine	Diagnostic / imaging agent	0.1 unknown	Other
Comparator	Gadopentetate dimeglumine	Diagnostic / imaging agent	0.1 unknown	Other

Indications